Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001520138-24-000434
Filing Date
2024-11-27
Accepted
2024-11-27 15:16:12
Documents
17

Document Format Files

Seq Description Document Type Size
1 FORM S-1 AMENDMENT NO. 1 bivi_s1a.htm   iXBRL S-1/A 50220
2 EXHIBIT 5.1 bivi_s1aex5z1.htm EX-5.1 18411
7 GRAPHIC image_02.jpg GRAPHIC 22221
8 GRAPHIC image_03.jpg GRAPHIC 15630
  Complete submission text file 0001520138-24-000434.txt   343857

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bivi-20240930.xsd EX-101.SCH 3272
4 XBRL DEFINITION FILE bivi-20240930_def.xml EX-101.DEF 29983
5 XBRL LABEL FILE bivi-20240930_lab.xml EX-101.LAB 36491
6 XBRL PRESENTATION FILE bivi-20240930_pre.xml EX-101.PRE 27037
19 EXTRACTED XBRL INSTANCE DOCUMENT bivi_s1a_htm.xml XML 5623
Mailing Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703
Business Address 680 W NYE LANE SUITE 201 CARSON CITY NV 89703 775-888-3162
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: S-1/A | Act: 33 | File No.: 333-283394 | Film No.: 241510467
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)